https://www.selleckchem.com/pr....oducts/trastuzumab.h
We provide here the first evidence that TO and CO reduce inflammatory airway hyperresponsiveness and certain cellular inflammatory parameters, so they can potentially be considered as adjuvant treatments in respiratory inflammatory conditions. In contrast, Ceylon type LO inhalation might have an irritant effect (e.g., increased airway hyperresponsiveness and MPO activity) on the inflamed airways, and therefore should be avoided.Deficits in plasma membrane repair have been identified in dysferlinopathy and Duchenne Muscular Dystrophy
Like
Comment
Share
